enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Rifaximin - Wikipedia

   en.wikipedia.org/wiki/Rifaximin

   Rifaximin, is a non-absorbable, broad spectrum antibiotic mainly used to treat travelers' diarrhea.It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in over more than 30 countries for the treatment of a variety of gastrointestinal diseases like irritable bowel syndrome, and hepatic encephalopathy.

3. Ciprofloxacin - Wikipedia

   en.wikipedia.org/wiki/Ciprofloxacin

   Ciprofloxacin is a fluoroquinolone antibiotic used to treat a number of bacterial infections. [5] This includes bone and joint infections, intra-abdominal infections, certain types of infectious diarrhea, respiratory tract infections, skin infections, typhoid fever, and urinary tract infections, among others. [5]

4. Antimotility agent - Wikipedia

   en.wikipedia.org/wiki/Antimotility_agent

   Bismuth subsalicylate (BSS) has both antibacterial and anti-secretory actions that help with diarrhea. [1] Once in the gut, BSS gets broken down into bismuth and salicylic acid. [ 1 ] Bismuth produces other bismuth salts, which blocks the binding and proliferation of bacteria in stomach mucosal cells, leading to a decrease in inflammation in ...

5. Travelers' diarrhea - Wikipedia

   en.wikipedia.org/wiki/Travelers'_diarrhea

   Diarrhea due to viral agents is unaffected by antibiotic therapy, but is usually self-limited. [13] Protozoans such as Giardia lamblia, Cryptosporidium and Cyclospora cayetanensis can also cause diarrhea. Pathogens commonly implicated in travelers' diarrhea appear in the table in this section. [13] [16]

6. 10% of travelers have had their medicines confiscated. Here's ...

   www.aol.com/10-travelers-had-medicines...

   According to a January survey of 1,245 Americans from BuzzRx, a prescription discounting service, one in 10 Americans have had their medicine confiscated while traveling, either by the ...

7. Rifamycin - Wikipedia

   en.wikipedia.org/wiki/Rifamycin

   Lepetit filed for patent protection of Rifamycin B in the UK in August 1958, and in the US in March 1959. The British patent GB921045 was granted in March 1963, and U.S. Patent 3,150,046 was granted in September 1964. The drug is widely regarded as having helped conquer the issue of drug-resistant tuberculosis in the 1960s.